Hyaluronan-enriched transfer medium in cleavage-stage frozen-thawed embryo transfers increases implantation rate without improvement of delivery rate

Fertil Steril. 2010 Oct;94(5):1669-73. doi: 10.1016/j.fertnstert.2009.10.019. Epub 2009 Nov 25.

Abstract

Objective: To investigate the efficacy of hyaluronan-enriched transfer media in cleavage-stage frozen embryo transfer cycles.

Design: Two commercially available transfer media were prospectively compared in an observational study.

Setting: Hospital-based in vitro fertilization clinic.

Patient(s): Patients (n = 425) undergoing frozen-thawed embryo transfer (FET). The embryos transferred were included in either a study group (high hyaluronic acid [HA], n = 199) or a control group (low HA, n = 226).

Intervention(s): Delivery rate per FET; positive hCG rate, biochemical pregnancy rate, clinical pregnancy rate, implantation rate, and clinical abortion rate were secondary outcomes.

Result(s): The use of HA in the transfer media significantly increased the positive hCG rate (37.2% vs. 25.2%) and implantation rate (23.1% vs. 15.8%) without increasing the delivery rate (21.6% vs. 21.2%). More subjects in the study group with a positive hCG test experienced biochemical pregnancy (28.4% vs. 8.9%).

Conclusion(s): Addition of HA to transfer media seems to favor attachment of early embryos in FETs without increasing the delivery rate.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Spontaneous / epidemiology
  • Adult
  • Cleavage Stage, Ovum / drug effects
  • Cleavage Stage, Ovum / physiology*
  • Embryo Implantation / drug effects*
  • Embryo Transfer / methods*
  • Female
  • Fertilization in Vitro / methods*
  • Humans
  • Hyaluronic Acid / pharmacology*
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Rate
  • Prevalence
  • Prospective Studies
  • Retrospective Studies

Substances

  • Hyaluronic Acid